EVOK News and Press, Evoke Pharma Inc. From 05/12/20

Evoke Pharma (NASDAQ: EVOK ): Q1 GAAP EPS of -$0.07 misses by $0.02 . More news on: Evoke Pharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Gimoti™ Prescription Drug User Fee Act (PDUFA) date is June 19, 2020 SOLANA BEACH, Calif., May 12, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced its financi...

New York City, NY: March 25, 2020 - Published via (Wired Release) - Recent Research and Future Market Potential of Gastroparesis Drugs Market in Global Industry: 2020 Research and New Innovations in Oil and Gas Sector. The prime objective of the report is to offer updates and information...

Evoke Pharma (NASDAQ: EVOK ): FY GAAP EPS of -$0.32 misses by $0.01 . More news on: Evoke Pharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

SOLANA BEACH, Calif., March 12, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced its financial results for the fourth quarter and full year ended December 31, 2019. ...

SOLANA BEACH, Calif., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for...

Sarepta Therapeutics ( SRPT ) fell victim to the FDA's whims as the stock tumbled more than 3 percent following the issues raised by the FDA against its drug candidate Vyondys 53 (golodirsen). The drug was earlier rejected by the FDA last year. However, given what we can only call "popular p...

Thinly traded nano cap Evoke Pharma (NASDAQ: EVOK ) perks up  10%  premarket on modestly higher volume on the heels of its agreement with life sciences commercial services provider Eversana for the commercialization and distribution of Gimoti (metoclopramide) nasal spray in the U...

EVERSANA to commercialize and distribute Gimoti in the U.S. EVERSANA to provide $5 million revolving credit facility upon FDA approval SOLANA BEACH, Calif. and CHICAGO, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focuse...

CSS Industries (NYSE: CSS ) +99%  on being acquired by IG Design Group plc. More news on: CSS Industries, Inc., Novavax, Inc., SemiLEDs Corporation, Stocks on the move, , Read more ...